表紙
市場調查報告書
商品編碼
1031497

神經血管設備的全球市場:疾病病情,各設備,各終端用戶,不同地區的預測(到2026年)- COVID-19累積的影響

Neurovascular Devices Market Research Report by Disease Pathology (Aneurysm, Arteriovenous Malformation and Fistulas, and Ischemic Stroke), by Devices, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日期: | 出版商: 360iResearch LLP | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球神經血管設備的市場規模在2020年估算為27億1,235萬美金,2021年28億8,920萬美元之後預計將以年複合成長率6.85%擴大,到2026年前將達到40億3,830萬美元。

本報告提供全球神經血管設備市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,疾病病情·設備·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 前提條件
  • 利害關係者

第2章 調查手法

  • 定義:調查目的
  • 決策:調查設計
  • 準備:調查設備
  • 收集:資料來源
  • 分析:資料的解釋
  • 制定:資料檢驗
  • 公開:調查報告
  • 重複:報告的更新

第3章 摘要整理

第4章 市場概要

  • COVID-19累積的影響

第5章 市場動態

  • 促進因素
    • 腦動脈瘤和神經病變的發生率增加
    • 腦外科微創手術需求增加
    • 神經血管裝置相關技術進展
  • 阻礙因素
    • 與神經血管介入和設備相關的高成本
  • 市場機會
    • 神經血管治療領域的新研究活動
    • 神經血管設備的持續產品開發和批准
  • 課題
    • 世界腦神經外科醫生有限

第6章 疾病病情的神經血管設備市場

  • 動脈瘤
  • 動靜脈畸形及造?口(AVM)
  • 缺血性中風
  • 狹窄

第7章 各設備的神經血管設備市場

  • 腦血管成形術及支架置入系統
    • 栓塞線圈
    • 分流器
    • 液體栓塞劑
  • 腦栓塞術及動脈瘤線圈栓塞術
    • 頸動脈支架
    • 栓塞保護系統
  • 神經血栓切除設備
    • 血塊回收設備
    • 吸引設備
    • 血管圈套
  • 支援設備
    • 微導管
    • 微導管導引線

第8章 各終端用戶的神經血管設備市場

  • 門診病人手術中心
  • 醫院
  • 專門診所

第9章 南北美洲的神經血管設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區的神經血管設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國

第11章 歐洲,中東·非洲的神經血管設備市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 各主要企業市場佔有率分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第13章 企業簡介

  • Abbott Laboratories
  • Acandis GmbH
  • B. BRAUN MELSUNGEN AG
  • Cerus Endovascular Inc.
  • Evasc Medical Systems
  • Gynesonics, Inc.
  • Integer Holdings Corporation
  • Integra Lifesciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Microport Scientific Corporation
  • Oxford Endovascular Ltd
  • Penumbra, Inc.
  • phenox GmbH
  • Rapid Medical
  • Secant Group, LLC
  • Sensome
  • Stryker Corporation
  • Terumo Corporation

第14章 附錄

  • 討論指南
  • 許可證和價格
目錄
Product Code: MRR-0360AB17E212

The Global Neurovascular Devices Market size was estimated at USD 2,712.35 million in 2020 and expected to reach USD 2,889.20 million in 2021, at a CAGR 6.85% to reach USD 4,038.30 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Neurovascular Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Disease Pathology, the market was studied across Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, and Stenosis.

Based on Devices, the market was studied across Cerebral Angioplasty and Stenting Systems, Cerebral Embolization and Aneurysm Coiling devices, Neurothrombectomy Devices, and Support Devices. The Cerebral Angioplasty and Stenting Systems is further studied across Embolic Coils, Flow Diverters, and Liquid Embolic Agents. The Cerebral Embolization and Aneurysm Coiling devices is further studied across Carotid Artery Stents and Embolic Protection Systems. The Neurothrombectomy Devices is further studied across Clot Retrieval Devices, Suction Devices, and Vascular Snares. The Support Devices is further studied across Micro Catheters and Micro Guidewires.

Based on End-User, the market was studied across Ambulatory Surgical Centers, Hospitals, and Specialized Clinics.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neurovascular Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Neurovascular Devices Market, including Abbott Laboratories, Acandis GmbH, B. BRAUN MELSUNGEN AG, Cerus Endovascular Inc., Evasc Medical Systems, Gynesonics, Inc., Integer Holdings Corporation, Integra Lifesciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Microport Scientific Corporation, Oxford Endovascular Ltd, Penumbra, Inc., phenox GmbH, Rapid Medical, Secant Group, LLC, Sensome, Stryker Corporation, and Terumo Corporation.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Neurovascular Devices Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurovascular Devices Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurovascular Devices Market?
  • 4. What is the competitive strategic window for opportunities in the Global Neurovascular Devices Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Neurovascular Devices Market?
  • 6. What is the market share of the leading vendors in the Global Neurovascular Devices Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Neurovascular Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Dynamics

  • 5.1. Introduction
  • 5.2. Drivers
    • 5.2.1. Increasing incidences of a brain aneurysm and neurological disorders
    • 5.2.2. Rising demand for minimally invasive procedures for brain surgeries
    • 5.2.3. Technological advancements related to neurovascular devices
  • 5.3. Restraints
    • 5.3.1. High cost associated with the neurovascular interventions and devices
  • 5.4. Opportunities
    • 5.4.1. Emerging research activities in the field of neurovascular therapies
    • 5.4.2. Ongoing product development and approvals of neurovascular devices
  • 5.5. Challenges
    • 5.5.1. Limited neurosurgeons across the globe

6. Neurovascular Devices Market, by Disease Pathology

  • 6.1. Introduction
  • 6.2. Aneurysm
  • 6.3. Arteriovenous Malformation and Fistulas (AVM)
  • 6.4. Ischemic Stroke
  • 6.5. Stenosis

7. Neurovascular Devices Market, by Devices

  • 7.1. Introduction
  • 7.2. Cerebral Angioplasty and Stenting Systems
    • 7.2.1. Embolic Coils
    • 7.2.2. Flow Diverters
    • 7.2.3. Liquid Embolic Agents
  • 7.3. Cerebral Embolization and Aneurysm Coiling devices
    • 7.3.1. Carotid Artery Stents
    • 7.3.2. Embolic Protection Systems
  • 7.4. Neurothrombectomy Devices
    • 7.4.1. Clot Retrieval Devices
    • 7.4.2. Suction Devices
    • 7.4.3. Vascular Snares
  • 7.5. Support Devices
    • 7.5.1. Micro Catheters
    • 7.5.2. Micro Guidewires

8. Neurovascular Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialized Clinics

9. Americas Neurovascular Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurovascular Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand

11. Europe, Middle East & Africa Neurovascular Devices Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Abbott Laboratories
  • 13.2. Acandis GmbH
  • 13.3. B. BRAUN MELSUNGEN AG
  • 13.4. Cerus Endovascular Inc.
  • 13.5. Evasc Medical Systems
  • 13.6. Gynesonics, Inc.
  • 13.7. Integer Holdings Corporation
  • 13.8. Integra Lifesciences Corporation
  • 13.9. Johnson & Johnson Services, Inc.
  • 13.10. Medtronic PLC
  • 13.11. Merit Medical Systems, Inc.
  • 13.12. MicroPort Scientific Corporation
  • 13.13. Microport Scientific Corporation
  • 13.14. Oxford Endovascular Ltd
  • 13.15. Penumbra, Inc.
  • 13.16. phenox GmbH
  • 13.17. Rapid Medical
  • 13.18. Secant Group, LLC
  • 13.19. Sensome
  • 13.20. Stryker Corporation
  • 13.21. Terumo Corporation

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 3. GLOBAL NEUROVASCULAR DEVICES MARKET: MARKET DYNAMICS
  • FIGURE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2020 VS 2026 (%)
  • FIGURE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2020 VS 2026 (USD MILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2026
  • FIGURE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, 2018-2026 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION AND FISTULAS (AVM), 2018-2026 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION AND FISTULAS (AVM), BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2020 VS 2026 (%)
  • FIGURE 16. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2026
  • FIGURE 18. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION AND ANEURYSM COILING DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION AND ANEURYSM COILING DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, 2018-2026 (USD MILLION)
  • FIGURE 29. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, 2018-2026 (USD MILLION)
  • FIGURE 31. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 33. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 34. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 35. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 37. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 41. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, 2018-2026 (USD MILLION)
  • FIGURE 43. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, 2018-2026 (USD MILLION)
  • FIGURE 45. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 47. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2026
  • FIGURE 49. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2026 (USD MILLION)
  • FIGURE 50. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 51. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 52. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 53. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 54. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 55. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 56. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 57. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 58. CANADA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 59. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 60. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 61. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 62. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 63. CHINA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 64. INDIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 65. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 66. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 67. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 68. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 69. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 70. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 71. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 72. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 73. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 74. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 75. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 76. ITALY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 77. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 78. QATAR NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 79. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 80. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 81. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 82. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 83. UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 84. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 85. GLOBAL NEUROVASCULAR DEVICES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 86. GLOBAL NEUROVASCULAR DEVICES MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 87. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEUROVASCULAR DEVICES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROVASCULAR DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION AND FISTULAS (AVM), BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION AND ANEURYSM COILING DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 17. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 18. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 19. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 20. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 21. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 22. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 23. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 24. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
  • TABLE 25. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 26. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 27. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 28. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. CANADA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. CHINA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. INDIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 45. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 46. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 47. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 48. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 49. ITALY NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 50. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 51. QATAR NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 52. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 53. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 54. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 55. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 56. UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 57. UNITED KINGDOM NEUROVASCULAR DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 58. GLOBAL NEUROVASCULAR DEVICES MARKET: SCORES
  • TABLE 59. GLOBAL NEUROVASCULAR DEVICES MARKET: BUSINESS STRATEGY
  • TABLE 60. GLOBAL NEUROVASCULAR DEVICES MARKET: PRODUCT SATISFACTION
  • TABLE 61. GLOBAL NEUROVASCULAR DEVICES MARKET: RANKING
  • TABLE 62. GLOBAL NEUROVASCULAR DEVICES MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 63. GLOBAL NEUROVASCULAR DEVICES MARKET: MERGER & ACQUISITION
  • TABLE 64. GLOBAL NEUROVASCULAR DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 65. GLOBAL NEUROVASCULAR DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 66. GLOBAL NEUROVASCULAR DEVICES MARKET: INVESTMENT & FUNDING
  • TABLE 67. GLOBAL NEUROVASCULAR DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 68. GLOBAL NEUROVASCULAR DEVICES MARKET: LICENSE & PRICING